Status of lipidsoluble antioxidants and TRAP in patients with Crohn's disease and healthy controls

European Journal of Clinical Nutrition

Volumn 53, Issue 9, 1999, Pages 675-679

  Genser, D ^a   Kang, M H ^b   Vogelsang, H ^c   Elmadfa, I ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b Hannam University   (South Korea)

^c NONE

Author keywords

Carotenoids; Crohn's disease; Lipidsoluble antioxidants; Tocopherols; TRAP (total radical trapping antioxidant potential); Ubiquinone

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; CAROTENOID; CRYPTOXANTHIN; GAMMA TOCOPHEROL; REACTIVE OXYGEN METABOLITE; RETINOL; TOCOPHEROL; UBIQUINONE;

ADULT; ARTICLE; AUSTRIA; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; MALE;

ADULT; ANTIOXIDANTS; CAROTENOIDS; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SMOKING; SOLUBILITY; UBIQUINONE; VITAMIN E;

EID: 0032831796     PISSN: 09543007     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1600764     Document Type: Article

References (32)

1. Albanes D, Heinonen OP, Huttunen JK, Taylor PR, Virtamo J, Edwards BK, Haapakoski J, Rautalahti M, Hartman AM, Palmgren J & Greenwald P (1995): Effects of α-tocopherol and β-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am. J. Clin. Nutr. 62 (suppl), S1427-S1430.
2. Best WR, Becktel JM, Singleton JW & Kern F (1976): Development of Crohn's disease activity index. National Cooperative Crohn's disease Study. Gastroenterology 70, 439-444.
3. Bousvaros A, Zurakowski D, Duggan C, Law T, Rifai N, Goldberg NE & Leichtner AM (1998): Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. JPGN 26, 129-135.
4. Buffinton GD & Doe WF (1995a): Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients. Free Radic. Res. 22, 131-134.
5. Buffinton GD & Doe WF (1995b): Depleted mucosal anitoxidant defences in inflammatory bowel disease. Free Radic. Biol. Med. 65, 911-918.
6. Emerit J, Pelletier S, Likforman J, Pasquier C & Thuillier A (1991): Phase II trial of copper zinc superoxide dismutase (CuZn SOD) in the treatment of Crohn's disease. Free Radic. Res. Commun. 12-13, 563-569.
7. Ernster L & Dallner G (1995): Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta 1271, 195-204.
8. Fernandez-Banares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabre E, Esteve M, Gonzalez-Huix F & Gassull MA (1989): Vitamin status in patients with inflammatory bowel disease. Am. J. Clin. Nutr. 84, 744-748.
9. Geerling BJ, Badart-Smook A, Stockbrügger RW & Brummer R-JM (1998): Comprehensive nutritional status in patients with long-standing Crohns' disease currently in remission. Am. J. Clin. Nutr. 67, 919-926.
10. Grisham MB, MacDermott RP & Deitch EA (1990): Oxidant defense mechanisms in the human colon. Inflammation 14, 669-680.
11. Hoffenberg EJ, Deutsch J, Smith S & Sokol RJ (1997): Circulating antioxidant concentrations in children with inflammatory bowel disease. Am. J. Clin. Nutr. 65, 1482-1488.
12. I, A, E and beta-carotene status in children (7-19 years). Internat. J. Vit. Nutr. Res. 65, 31-35.
13. Janczewska I, Bartnik W, Butruk E, Tomecki R, Kazik E & Ostrowski J (1991): Metabolism of vitamin A in inflammatory bowel disease. Hepato-Gastroenterol 38, 391-195.
14. Jeejebhoy KN (1998): The many facets of malnutrition in Crohn's disease. Am. J. Clin. Nutr. 67, 819-820.
15. Kang M-H, Genser D & Elmadafa I (1997): Increased sister chromatid exchanges in peripheral lymphocytes of patients with Crohn's disease. Mutation Res. 381, 141-148.
16. Kelly DG & Fleming CR (1995): Nutritional considerations in inflammatory bowel diseases. Gastroenterol Clinics of North America. 24, 597-611.
17. Kimura H, Miura S, Shigematsu T, Ohkubo N, Tsuzuki Y, Kurose I, Higuchi H, Akiba Y, Hokari R, Hirokawa M, Serizawa H & Ishii H (1997): Increased nitric oxid production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's Disease. Dig. Dis. Sci. 42, 1047-1054.
18. Kuroki F, Iida M, Tominaga M, Matsumoto T, Hirakawa K, Sugiyama S & Fujishima M (1993): Multiple vitamin status in Crohn's disease. Correlation with disease activity. Dig. Dis. Sci. 38, 1614-1618.
19. Kuroki F, Iida M, Tominaga M, Matsumoto T, Kanamoto K & Fujishima M (1994): Is Vitamin E depleted in Crohn's disease at initial diagnosis? Dig. Dis. 12, 248-254.
20. Lee KH, Abe S, Yanabe Y, Matsuda I & Yoshida MC (1990): Superoxide dismutase activity and chromosome damage in cultured chromosome instability syndrome cells. Mutation Res. 244, 251-256.
21. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, McKinley MJ, Fisher SE & Mullin GE (1996): Increased oxidative stress and decreased antioxidant defences in mucosa of inflammatory bowel disease. Dig. Dis. Sci. 41, 2078-2086.
22. MacDermott RP (1997): Etiology and pathogenesis of inflammatory bowel disease. Current Opinion in Gastroent. 13, 302-306.
23. Malchow H, Ewe K, Brandes JW, Goebell H, Ehms H, Sommer H & Jeschinsky H (1984): European Cooperative Crohn's Disease Study (ECCDS): Results of Drug Treatment. Gastroenterology 86, 249-266.
24. Miller NJ, Sampson J, Candeias LP, Bramley PM & Rice-Evans CA (1996): Antioxidant activities of carotenes and xanthophylls. FEBS Letters 348, 240-242.
25. Nielsen OH & Ahnfelt-Rønne I (1991): Involvement of oxygen-derived free radicals in the pathogenesis of chronic inflammatory bowel disease. Klin. Wochenschr. 69, 995-1000.
26. Proulx M, Maupoil V, Rochette L & du-Souich P (1995): Increase in antilipoperoxidant activity of plasma as a consequence of an inflammatory reaction induced by subcutaneous turpentine in the rabbit. Free Radic. Res. 23, 245-254.
27. Rice-Evans C & Miller NJ (1994): Total antioxidant status in plasma and body fluids. Methods in Enzymology 234, 279-293.
28. Schölmerich J, Becher MS, Hoppe-Seyler P, Matern S, Häussinger D, Loehle E, Koettgen E & Gerok W (1985): Zinc and Vitamin A deficiency in patients with Crohn's disease is correlated with activity but not with localization or extent of the disease. Hepatogastroenterology 32, 34-38.
29. Simmonds NJ & Rampton DS (1993): Inflammatory bowel disease - a radical view. Gut 34, 865-868.
30. Sobirey M, Schlotzer E, Manns K & Elmadfa I (1986): Untersuchungen über den Einfluss von Vitamin E auf eine experimentelle Entzündung an Ratten. Z. gesamte inn. Med. 41, 652-657.
31. Vogelsang H, Ferenci P, Schilling R, Woloszczuk W, Haschke F, Lochs H, Meryn S & Gangl A (1994): Vitamin D status in outpatients with Crohn's Disease. Europ. J. Gastroenterol. Hepatol. 6, 513-517.
32. Wolf G (1997): gamma-Tocopherol: an efficient protector of lipids against nitric oxide-initiated peroxidative damage. Nutr. Rev. 55, 376-378.